BCC Research highlights that Cellino Biotech secured $25 million from ARPA-H in 2024 for AI-guided biomanufacturing in personalized regenerative medicine.
Public source
Publisher name
Public post
"Corporate AI investment reached $252.3 billion in 2024 — a 44.5% rise in private funding and a 13-fold increase since 2014. A significant and growing share of that capi…
Company
BCC Research
Your trusted custom research and data analysts.
- Industry
- Market Research
- Location
- Boston, US
- Company size
- 201–500 employees
About BCC Research
Your trusted custom research and data analysts. At BCC Research, our mission is to provide businesses with reputable data and market research reports to better understand their field and target audience. We are dedicated to helping companies access reliable information, accurate forecasts, and actionable insights, to become a leader in their industry. Our goal is to help businesses make smart decisions based on data-driven insights, giving a competitive edge in their industry. We do this by creating a comprehensive analysis of trending topics, forecasting, and industry intelligence. We are with you, every step of the way! Reach out today to learn more.
See moreLatest activity
Latest activity from BCC Research
11 signals
Capital & Finance
BCC Research highlights that Morphocell Technologies completed a $50 million Series A and is expanding into Europe.
Capital & Finance
BCC Research highlights that Aspect Biosystems raised $115 million in a Series B round in January 2025 to advance AI-powered bioprinted tissue therapies.
Research & Knowledge
BCC Research published its latest Pulse Report titled AI Impact on Functional Foods and Beverages examining technologies, investment trends, key players, and strategic implications shaping the market.
Discover more
Similar signals
Similar public activity from other companies.
Capital & Finance
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine reported seven approvals between the United States and the European Union for its near-term cell and gene therapy pipeline in 2026.
Capital & Finance
Mass General Brigham Research
Mass General Brigham Research has been awarded up to $39.2 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop a new platform designed to make personalized genetic medicines faster, more affordable, and more accessible.
Capital & Finance
Termeer Institute
Termeer Institute's Probably Genetic has been awarded up to $10 million from ARPA-H to build the world's largest AI-ready rare disease dataset.
Capital & Finance
BioCrowd
BioCrowd is funding $90 million into three science and technology centers for 5 years.
Capital & Finance
Signify Research Ltd